HR Execs on the Move

BRI Biopharmaceutical Research Inc

www.bripharm.com

 
BRI Biopharmaceutical Research Inc is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Wexner Heritage Village

Wexner Heritage Village is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Wexner Heritage Village is based in Columbus, OH. You can find more information on Wexner Heritage Village at www.whv.org

Sechrist Industries

Sechrist Industries Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Sechrist Industries Inc. is based in Anaheim, CA. You can find more information on Sechrist Industries Inc. at www.sechristind.com

North Canton Medical Foundation

North Canton Medical Foundation was founded in 1972 by a group of physicians who envisioned a non-profit physician group practice as a unique mechanism to bring high quality medical care to the community. Since 1972, North Canton Medical Foundation has

Mediant Health Resources

Mediant Health Resources is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Uroplasty

Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.